Maryland Medicaid and GLP-1s

What changed, and what the document says

1. Chronic weight management is not a covered reason

   Not covered

   The transmittal that opened Maryland's Wegovy coverage says what it is not for, in the same breath as what it is for.

   “Wegovy will not be covered when the sole indication is for chronic weight management”

   Maryland Medical Assistance Program, Medical Benefits Management — September 13, 2024

2. But the form still wants a failed weight-loss attempt

   Conditions apply

   An attestation on a benefit that is not for weight loss, asking the prescriber to confirm that weight loss was attempted and did not work.

   “Patient has engaged in a trial of weight loss management in the past 6 months and failed to achieve weight loss.”

   Maryland Medicaid, Office of Pharmacy Services — MDH - 12/2025

3. A BMI no older than ninety days

   Conditions apply

   Maryland dates the measurement rather than accepting a number from the chart.

   “Patient has BMI of 27kg/m2 or greater within the last 90 days”

   Maryland Medicaid, Office of Pharmacy Services — MDH - 12/2025

4. A cardiologist on the request

   Conditions apply

   The cardiovascular route needs a cardiologist's involvement, which is a referral before it is a prescription.

   “Prescribed by or in consultation with a cardiologist”

   Maryland Medicaid, Office of Pharmacy Services — MDH - 12/2025

5. No stacking

   Conditions apply

   Stated twice on one form, once under each drug.

   “Patient not concurrently using any other GLP-1 receptor agonists.”

   Maryland Medicaid, Office of Pharmacy Services — MDH - 12/2025

6. A sleep study with a number attached

   Conditions apply

   The Zepbound half of the form sets the same threshold most states use and asks for the index itself.

   “study with an apnea-hypopnea index (AHI) ≥ 15 events per hour with obesity”

   Maryland Medicaid, Office of Pharmacy Services — MDH - 12/2025

7. Priced per invoice, not per claim

   Context

   An unusual billing detail from the transmittal: Maryland reimbursed this through a procedure code priced off the invoice.

   “The Medicaid FFS program will reimburse Wegovy under HCPCS code J3490”

   Maryland Medical Assistance Program, Medical Benefits Management — September 13, 2024

Which of these companies serve Maryland?

Of the 387 companies we grade, 34 publish a list of the states they are licensed in. We checked 251 more and found no such list on any page we read; 102 we have not checked either way.

22 of those lists name Maryland: Gala Health, Care Bare Rx, Vita Bella, TelePeptide, Levity, Wisp, WePeptideRx, Ways2Well, TeleClinic, Tyde Wellness, Willow, VevaRx, Trimi, Enhance MD, HumeCare+, Rx.com, Mojoon, Peak Wellness, Sprout Health, Allara Health, MEDvidi, and Mixx Health & Wellness. That is a licensure claim each company makes about itself, not something we checked with a state board.

A published list is a starting point, not a guarantee. If availability decides your choice, ask before you pay and get the answer in writing.

Coverage decides what you pay before cash does. See how state Medicaid programs cover GLP-1s and what a prior-authorization denial turns on.